Home » Topics » Regulatory

Regulatory
RSS

FDA approves Clozaril to reduce the risk of suicidal behavior

Jan. 9, 2003

Pfizer launches three-day antibiotic for middle ear infections

Jan. 9, 2003

Finacea approved for topical treatment of rosacea

Jan. 9, 2003

sNDA filed for Seroquel in acute mania associated with bipolar disorder

Jan. 8, 2003

Zovirax approved by FDA for recurrent cold sores

Jan. 8, 2003

Zyvox approved for bacterial infections in infants and children

Jan. 8, 2003

Endo submits NDA for extended-release oxymorphone

Jan. 8, 2003

Metformin XT NDA submitted for type 2 diabetes

Jan. 8, 2003

Restasis receives FDA approval

Jan. 7, 2003

Topamax sNDA submitted for migraine prevention

Jan. 7, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...